{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:56:02Z","timestamp":1790502962258,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neuropharm.2020.108407","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:17:56Z","timestamp":1605525476000},"page":"108407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Long-lasting analgesic and neuroprotective action of the non-benzodiazepine anxiolytic etifoxine in a mouse model of neuropathic pain"],"prefix":"10.1016","volume":"182","author":[{"given":"Nisrine","family":"Kamoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Gazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Goumon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Andry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick","family":"Poisbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108407_bib1","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1523\/JNEUROSCI.4173-05.2005","article-title":"Neurosteroid access to the GABAA receptor","volume":"25","author":"Akk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2012.06.033","article-title":"Chronic pain leads to concomitant noradrenergic impairment and mood disorders","volume":"73","author":"Alba-Delgado","year":"2013","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108407_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pain.2009.08.001","article-title":"Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3alpha-reduced neurosteroids","volume":"147","author":"Aouad","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/j.1532-2149.2013.00367.x","article-title":"Etifoxine stimulates allopregnanolone synthesis in the spinal cord to produce analgesia in experimental mononeuropathy","volume":"18","author":"Aouad","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pain.2013.11.003","article-title":"Etifoxine analgesia in experimental monoarthritis: a combined action that protects spinal inhibition and limits central inflammatory processes","volume":"155","author":"Aouad","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.biopsych.2017.01.019","article-title":"Cingulate overexpression of mitogen-activated protein kinase phosphatase-1 as a key factor for depression","volume":"82","author":"Barthas","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108407_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejpain.2007.10.002","article-title":"Sciatic nerve cuffing in mice: a model of sustained neuropathic pain","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3389\/fnins.2019.01268","article-title":"Monoamines as drug targets in chronic pain: focusing on neuropathic pain","volume":"13","author":"Bravo","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neubiorev.2020.04.029","article-title":"Pain in neuropsychiatry: insights from animal models","volume":"115","author":"Bravo","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2020.108407_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2020.108407_bib12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/acschemneuro.7b00027","article-title":"The anxiolytic etifoxine binds to TSPO ro5-4864 binding site with long residence time showing a high neurosteroidogenic activity","volume":"8","author":"Costa","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nature01868","article-title":"Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain","volume":"424","author":"Coull","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108407_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature04223","article-title":"BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain","volume":"438","author":"Coull","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108407_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2007.02.019","article-title":"Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine","volume":"563","author":"Egashira","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejphar.2018.12.018","article-title":"Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization","volume":"843","author":"Gazzo","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib18","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/JME-12-0127","article-title":"Neuroactive steroids, their metabolites, and neuroinflammation","volume":"49","author":"Giatti","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib19","doi-asserted-by":"crossref","first-page":"20505","DOI":"10.1073\/pnas.0811201106","article-title":"Etifoxine improves peripheral nerve regeneration and functional recovery","volume":"105","author":"Girard","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108407_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2826.2011.02215.x","article-title":"Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa","volume":"24","author":"Girard","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2008.04.043","article-title":"Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat","volume":"213","author":"Goncalves","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib23","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108407_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neuropharm.2020.108407_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108407_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108407_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00441-019-03003-z","article-title":"The molecular neurobiology of chronic pain-induced depression","volume":"377","author":"Humo","year":"2019","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2020.108407_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2014.12.022","article-title":"Characterization of the fast GABAergic inhibitory action of etifoxine during spinal nociceptive processing in male rats","volume":"91","author":"Juif","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108407_bib29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nn.2407","article-title":"Unmasking the tonic-aversive state in neuropathic pain","volume":"12","author":"King","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pain.2008.10.015","article-title":"Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice","volume":"141","author":"Knabl","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108407_bib32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib33","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3389\/fimmu.2019.01696","article-title":"The role of inflammation in depression and fatigue","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1159\/000442204","article-title":"Progesterone improves neurobehavioral outcome in models of intracerebral hemorrhage","volume":"103","author":"Lei","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.108407_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11940-005-0032-0","article-title":"Chronic pain and comorbid depression","volume":"7","author":"Leo","year":"2005","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PSY.0000000000000158","article-title":"Longitudinal associations between depression, anxiety, pain, and pain-related disability in chronic pain patients","volume":"77","author":"Lerman","year":"2015","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2020.108407_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-017-0921-7","article-title":"A translocator protein 18 kDa agonist protects against cerebral ischemia\/reperfusion injury","volume":"14","author":"Li","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2020.108407_bib38","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1096\/fj.201601377RR","article-title":"A TSPO ligand attenuates brain injury after intracerebral hemorrhage","volume":"31","author":"Li","year":"2017","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2020.108407_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.psyneuen.2017.05.022","article-title":"Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: pharmacodynamic studies","volume":"83","author":"Liere","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.108407_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fendo.2011.00055","article-title":"Neurosteroids as neuromodulators in the treatment of anxiety disorders","volume":"2","author":"Longone","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib41","doi-asserted-by":"crossref","first-page":"104250","DOI":"10.1016\/j.phrs.2019.04.034","article-title":"Involvement of the GABAA receptor alpha subunit in the mode of action of etifoxine","volume":"145","author":"Mattei","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2020.108407_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1472-8206.2001.00025.x","article-title":"A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected]","volume":"15","author":"Micallef","year":"2001","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mico","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2013.01.070","article-title":"GABA(A) receptor modulation: potential to deliver novel pain medicines?","volume":"716","author":"Munro","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib45","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nn.3811","article-title":"Reward and motivation in pain and pain relief","volume":"17","author":"Navratilova","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.757","article-title":"Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice","volume":"21","author":"Nguyen","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2011.05.005","article-title":"Mechanisms of neuropathic pain","volume":"22","author":"Nickel","year":"2012","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108407_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Njung'e","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108407_bib50","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1080\/15622975.2018.1468030","article-title":"Anxiolytics targeting GABAA receptors: insights on etifoxine","volume":"19","author":"Poisbeau","year":"2018","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108407_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fncel.2014.00174","article-title":"Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone","volume":"8","author":"Poisbeau","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108407_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/bs.pmbts.2014.11.008","article-title":"Synaptic inhibition and disinhibition in the spinal dorsal horn","volume":"131","author":"Prescott","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib54","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/j.1532-2149.2013.00334.x","article-title":"Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study","volume":"17","author":"Radat","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108407_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuropharm.2016.03.053","article-title":"Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis","volume":"108","author":"Ravikumar","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108407_bib56","doi-asserted-by":"crossref","DOI":"10.2174\/1871527319666200601151007","article-title":"In vitro and in vivo neuroprotective effects of etifoxine in beta-amyloid-Induced toxicity models","author":"Riban","year":"2020","journal-title":"CNS Neurol. Disord. Drug Targ."},{"key":"10.1016\/j.neuropharm.2020.108407_bib57","first-page":"CD005454","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2020.108407_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-398314-5.00001-5","article-title":"Inflammation in anxiety","volume":"88","author":"Salim","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2020.108407_bib59","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0028-3908(99)00253-1","article-title":"Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine","volume":"39","author":"Schlichter","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108407_bib60","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1523\/JNEUROSCI.3195-17.2018","article-title":"Hyperactivity of anterior cingulate cortex areas 24a\/24b drives chronic pain-induced anxiodepressive-like consequences","volume":"38","author":"Sellmeijer","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib61","first-page":"569","article-title":"Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study","volume":"24","author":"Servant","year":"1998","journal-title":"Encephale"},{"key":"10.1016\/j.neuropharm.2020.108407_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112639","article-title":"Reduction of traumatic brain damage by tspo ligand etifoxine","volume":"20","author":"Shehadeh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108407_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-016-0687-3","article-title":"Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury","volume":"13","author":"Simon-O'Brien","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2020.108407_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12325-015-0176-6","article-title":"Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial","volume":"32","author":"Stein","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.neuropharm.2020.108407_bib65","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1213\/01.ane.0000261514.19946.66","article-title":"Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression","volume":"104","author":"Suzuki","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2020.108407_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40122-017-0088-z","article-title":"A review of the emotional aspects of neuropathic pain: from comorbidity to Co-pathogenesis","volume":"6","author":"Torta","year":"2017","journal-title":"Pain Ther."},{"key":"10.1016\/j.neuropharm.2020.108407_bib67","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108407_bib68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.brainresrev.2004.07.004","article-title":"Descending control of persistent pain: inhibitory or facilitatory?","volume":"46","author":"Vanegas","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2020.108407_bib69","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1097\/00001756-199910190-00015","article-title":"Interactions of etifoxine with the chloride channel coupled to the GABA(A) receptor complex","volume":"10","author":"Verleye","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.108407_bib70","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.pbb.2005.11.013","article-title":"The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain","volume":"82","author":"Verleye","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108407_bib71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0035-1558003","article-title":"Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines","volume":"48","author":"Wolf","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2020.108407_bib72","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00213-008-1227-3","article-title":"Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice","volume":"200","author":"Yalcin","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2020.108407_bib73","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.biopsych.2011.07.017","article-title":"A time-dependent history of mood disorders in a murine model of neuropathic pain","volume":"70","author":"Yalcin","year":"2011","journal-title":"Biol. Psychiatr."},{"issue":"89","key":"10.1016\/j.neuropharm.2020.108407_bib74","first-page":"51608","article-title":"The sciatic nerve cuffing model of neuropathic pain in mice","volume":"2014","author":"Yalcin","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2020.108407_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/physrev.00043.2010","article-title":"Fast synaptic inhibition in spinal sensory processing and pain control","volume":"92","author":"Zeilhofer","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108407_bib76","doi-asserted-by":"crossref","first-page":"100196","DOI":"10.1016\/j.ynstr.2019.100196","article-title":"Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond","volume":"11","author":"Zorumski","year":"2019","journal-title":"Neurobiol Stress"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:07:48Z","timestamp":1758438468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820304755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":76,"alternative-id":["S0028390820304755"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108407","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-lasting analgesic and neuroprotective action of the non-benzodiazepine anxiolytic etifoxine in a mouse model of neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108407"}}